Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a radiation oncology company that manufactures and sells precise, leading-edge treatment solutions that revolve around the patient. Accuray's innovative technologies – the CyberKnife and TomoTherapy Systems – set the standard of care with the aim of helping patients live longer, better lives. For more information, please visit
Sunnyvale, US
1,010 (est)
Accuray is headquartered in Sunnyvale, US

Accuray Locations

Sunnyvale, US
Morges, CH
Madison, US
Chengdu, CN
New York, US
Chiyoda, JP
Shanghai, CN

Accuray Metrics

Accuray Summary

Market capitalization

$441 M

Closing share price

Accuray's current market capitalization is $441 M.

Accuray Financials

Accuray's revenue is $399 M in FY, 2016 which is 5.0% increase from the previous period.
FY, 2014FY, 2015FY, 2016


$369 M$380 M$399 M

Gross profit

$143 M$145 M$159 M

Operating income

$-18.1 M$-19.2 M$-4.87 M

Operating expense total

$161 M$165 M$164 M

Net Income

$-35.4 M$-40.2 M$-25.5 M

Operating cash flow

$19 M$-12.8 M$40.2 M

    Accuray Market Value History

    Accuray Online Presence

    Accuray News

    Accuray Company Life